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RESEARCH ARTICLE

Open Access

The effects of anatabine on non-invasive
indicators of muscle damage: a randomized,
double-blind, placebo-controlled, crossover study
Nathaniel DM Jenkins, Terry J Housh, Glen O Johnson, Daniel A Traylor, Haley C Bergstrom, Kristen C Cochrane,
Robert W Lewis, Jr., Richard J Schmidt and Joel T Cramer*

Abstract
Background: Anatabine (ANA), a minor tobacco alkaloid found in the Solanaceae family of plants, may exhibit
anti-inflammatory activity, which may be useful to aid in recovery from exercise-induced muscle damage. The
purpose of this study, therefore, was to examine the effects of ANA supplementation on the recovery of isometric
strength and selected non-invasive indicators of muscle damage.
Methods: A double-blinded, placebo-controlled, crossover design was used to study eighteen men (mean ± SD
age = 22.2 ± 3.1 yrs; body mass = 80.3 ± 15.7 kg) who participated in two randomly-ordered conditions separated by
a washout period. The ANA condition consisted of consuming 6–12 mg anatabine per day for 10 days, while
testing took place during days 7–10. The placebo (PLA) condition was identical except that the PLA supplement
contained no ANA. Maximal voluntary isometric peak torque (PT) of the forearm flexors, arm circumference,
hanging joint angle, and subjective pain ratings were measured before (PRE), immediately after (POST), and 24, 48,
and 72 h after six sets of 10 maximal, eccentric isokinetic forearm flexion muscle actions. Resting heart rate and
blood pressure were measured at PRE and 72 h in each condition.
Results: For PT, hanging joint angle, arm circumference, and subjective pain ratings, there were no condition x
time (p > 0.05) interactions, there were no main effects for condition (p > 0.05), but there were main effects for time
(p < 0.001). There were no condition x time (p > 0.05) interactions and no main effects for condition (p > 0.05) or
time (p > 0.05) for blood pressure or resting heart rate.
Conclusions: ANA supplementation had no effect on the recovery of muscle strength, hanging joint angle, arm
swelling, or subjective pain ratings after a bout of maximal eccentric exercise in the forearm flexors. Therefore, ANA
may not be beneficial for those seeking to improve recovery from heavy eccentric exercise. Future studies should
examine the effects of ANA on the pro-inflammatory cytokine responses to exercise-induced muscle damage and
the chronic low-grade inflammation observed in obese and elderly individuals.
Keywords: Anatabine, Supplementation, Eccentric muscle damage, Delayed onset muscle soreness,
Muscle function

Background
Unaccustomed eccentric exercise often results in
muscle damage and delayed onset muscle soreness
(DOMS). The symptoms of eccentric-induced muscle
damage include loss of strength, limited range of motion, swelling, pain, and tenderness [1,2]. While the
* Correspondence: jcramer@unl.edu
Department of Nutrition and Health Sciences, University of Nebraska-Lincoln,
211 Ruth Leverton Hall, Lincoln, NE 68583-0806, USA

exact mechanisms responsible for these symptoms are
not fully understood, the structural damage caused by
eccentric exercise is characterized by disorganization of
myofilaments, z-line widening and streaming [3,4], interruption of the excitation-contraction coupling process [5],
and an immune response that produces an accumulation
of mononuclear cells [1]. It is also possible that neural
mechanisms, such as the inability to fully activate muscles,
may contribute to the loss of strength following eccentric
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exercise [6,7]. Thus, several factors contribute to the manifestation of eccentric-induced symptoms of muscle damage
and DOMS. As a result, studies have examined a variety of
treatments to reduce damage or improve recovery after eccentric exercise, such as therapeutic modalities (i.e., massage, cryotherapy, and stretching), pharmacological
treatments (i.e., non-steroidal anti-inflammatory drugs),
and dietary supplementation.
Lund et al. [8] showed no effects of passive stretching
on muscle strength or muscle pain after eccentricinduced muscle damage in the leg extensors. Tokmakidis
et al. [9] demonstrated that ibuprofen (400 mg every
8 hours for 48 hrs) decreased muscle soreness at 24 h
after eccentric exercise, however, there were no differences in the recovery of muscle strength or range of motion compared to placebo. In addition, Connolly et al.
[10] found that tart cherry juice supplementation attenuated the losses in muscle strength and decreased muscle
pain after eccentric-induced muscle damage when compared to a placebo. Consequently, treatments that may
reduce inflammation can help to improve recovery or alleviate the symptoms associated with exercise-induced
muscle damage.
Anatabine (ANA) is a minor alkaloid with a similar
chemical structure to nicotine that is found in the tobacco
plant and the Solanaceae family of plants (i.e., green tomatoes, eggplant, and peppers). Recent studies have observed
anti-inflammatory effects of ANA [11,12]. For example,
ANA lowered NFkB activation and limited amyloid beta
production, both of which are associated with plaque
deposits in the brain, in Alzheimer’s disease [11] and the
over-production of brain inflammatory cytokines [12].
ANA has also been shown to prevent the production of
interleukin-1 beta (IL-1β), interleukin 6 (IL-6), and tumor
necrosis factor alpha (TNF-α) induced by lipopolysaccharides in human blood and in mice [12]. Theoretically,
therefore, ANA may attenuate the decreases in muscle
strength following eccentric-induced muscle damage by
reducing inflammation and the production of proinflammatory cytokines, since muscle strength is commonly
identified as the single best non-invasive indicator of
muscle damage [2]. For instance, Beck et al. [13] demonstrated attenuated losses in muscle strength with protease
supplementation following eccentric-induced muscle damage, which was explained by the potential anti-inflammatory effects of the protease supplement. Therefore, using
the same experimental model as Beck et al. [13], the purpose of this study was to examine the effects of ANA supplementation on the recovery of isometric strength and
selected non-invasive indicators of muscle damage. A second objective was to assess the effects of short-term ANA
supplementation on heart rate and blood pressure.
We hypothesized that ANA would attenuate losses in
muscular strength and improve the recovery of the

Page 2 of 8

hanging joint angle, relaxed arm circumference, and subjective pain ratings due to its potential anti-inflammatory
properties. We also hypothesized that ANA supplementation would result in moderate decreases in blood pressure
and small increases in heart rate because of its similar
chemical structure to nicotine [14].

Methods
Participants

Twenty men (mean ± SD age = 22.4 ± 3.0 yrs; body mass =
79.4 ± 15.5 kg; height = 182.9 ± 6.5 cm) volunteered to participate in this investigation, which was approved by the
university Institutional Review Board for the protection of
human participants. Two men consumed less than 70% of
the study product and were subsequently considered noncompliant and excluded from data analysis. Therefore,
only the data from the 18 compliant men (mean ± SD
age = 22.2 ± 3.1 yrs; body mass = 79.7 ± 16.1 kg; height =
182.9 ± 6.5 cm) were analyzed and reported for this
study. Prior to any testing at visit 1, participants signed an
informed consent form and completed a health history
questionnaire. Each participant was free from current or
ongoing neuromuscular diseases or musculoskeletal injuries involving the wrist, elbow, and shoulder joints. None
of the participants had acute infections nor had they engaged in any upper-body resistance training during the
6 months prior to enrollment. In addition, none of the
participants reported smoking, use of smokeless tobacco,
or use of creatine within 9 weeks prior to enrollment. All
of the participants were instructed to maintain their normal dietary habits and avoid the use of anti-inflammatory
or pain medications throughout the duration of the study.
Experimental design

This study used a randomized, double-blinded, placebocontrolled, crossover design (Figure 1). At visit 1, the
participants were randomly assigned to either a supplement (anatabine, ANA) or placebo (PLA) condition
based on their assigned participant number and corresponding randomization code. The participants returned
to the laboratory for visit 2 seven days (± 1 day) after
visit 1, and data were recorded for unilateral maximal
voluntary isometric forearm flexion strength, hanging
joint angle, relaxed arm circumference, and subjective
pain rating. Each of these tests was performed immediately prior to (PRE), immediately following (POST), and
24, 48, and 72 h after the bout of maximal eccentric isokinetic forearm flexion exercise (Figure 1). Following a
washout period of 2–4 weeks, participants returned for
visit 6 to undergo either the ANA or PLA condition,
whichever was not administered during visits 1–5. During the crossover (visits 6–10), the participants performed the same series of tests as visits 1–5. The
dependent variables in this study were maximal
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Figure 1 Schematic of the testing schedule for visits 1–5 and visits 6–10. Testing was performed before (PRE), immediately after (POST), and
24, 48, and 72 h after the eccentric exercise. *The order of tests are numbered sequentially.

voluntary isometric forearm flexion strength, hanging
joint angle, relaxed arm circumference, and subjective
pain rating measured during visit 2–5 and visits 7–10,
while resting systolic and diastolic blood pressure and
resting heart rate were only measured at baseline and
72 h (visits 1, 5, 6, and 10). Figure 1 displays the numeric
order of tests performed at each visit. The independent
variables in this study were condition (ANA or PLA)
and time (PRE, POST, 24, 48, and 72 h), and both were
within-subjects repeated measures variables.
Supplementation

The ANA and PLA dietary supplements were administered as mint-flavored mannitol granulation lozenges.
Each ANA lozenge contained 3 mg of anatabine, 834 IU
vitamin A, and 66 IU vitamin D3. The PLA lozenge
contained everything in the ANA lozenge except for
anatabine and was identical in flavor and appearance to
the ANA lozenge. The participants were given a 10 day

supply of study product (ANA or PLA) at visits 1 and 6
and were instructed to self-administer the lozenges with
food two or three times per day beginning after visit 1
(Figure 1).The schedule for consuming the lozenges
during each 10 day period was as follows: (a) 1 lozenge
at breakfast and lunch on days 1 and 2, (b) 1 lozenge at
breakfast, lunch, and dinner on days 3 and 4, and (c) 2
lozenges at breakfast and 1 at lunch and dinner on days
5–10. Therefore, during the ANA condition, the participants consumed 6 mg of ANA during days 1 and 2, 9 mg
during days 3 and 4, and 12 mg during days 5 through 10.
The participants did not take any study product during
the washout period of two to four weeks (Figure 1).
Compliance was assessed when all unused study product was returned to the laboratory at visits 5 and 10.
The amount of unused product was counted and used
to calculate compliance. The average compliance was
(mean ± standard deviation) 95.3 ±7.7%, and compliance
ranged between 74% and 104% for all 18 participants.

Jenkins et al. Journal of the International Society of Sports Nutrition 2013, 10:33
http://www.jissn.com/content/10/1/33

Eccentric exercise protocol

During visits 2 and 7 (Figure 1), the participants completed an eccentric exercise protocol that consisted of 6
sets of 10 maximal eccentric isokinetic muscle actions
of the forearm flexors at 30° s-1. The exercised arm
(right or left) used during visit 2 was determined at visit
1 using a separate randomization, and the opposite arm
was exercised at visit 7. Connolly et al. [15] reported
that about of eccentric exercise in one limb does not
confer a protective effect against muscle damage in the
opposite limb two weeks later.
Participants were placed in a supine position on an upper
body exercise testing bench with a strap placed around the
waist to prevent excessive movement (Figure 2). The eccentric muscle actions were performed with a neutral
hand position. One min of rest was given between each
set. Strong verbal encouragement was provided throughout the protocol to ensure that a maximal effort was given.
Following the eccentric exercise protocol, 2 min of rest
was provided prior to the POST exercise assessments.
Isometric strength

Participants were placed on an upper body exercise
testing bench as previously described (Figure 2).
Following a warm-up of 5 submaximal muscle actions
at 50% of maximal effort, the participants performed
two 6-s maximal voluntary isometric muscle actions
(MVICs) of the forearm flexors separated by 2 min of
rest. The MVICs were performed with a neutral hand
position. Torque was recorded with a calibrated isokinetic dynamometer (Cybex 6000, CYBEX Division,
LUMEX Inc., Ronkonkoma, NY). Prior to the isometric
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muscle actions, the limb was weighed and gravity
corrected using HUMAC software (HUMAC2009, CSMi,
Stoughton, MA). During the isometric muscle actions,
the joint angle between the arm and forearm was set at
115° (65° from full extension), and the angle between
the arm and trunk was set at 45° (45° of abduction). In
order to remove any free play from the dynamometer
lever arm, the investigator placed a minimal baseline
pressure on the lever arm prior to the initiation of the
MVICs. Careful instruction was given to each participant to ensure that they contracted as “hard and fast”
as possible. The highest torque output (Nm) provided
by the HUMAC software for the two MVICs was defined as the peak torque (PT) and was used for subsequent analyses.
Hanging joint angle and relaxed arm circumference

The hanging joint angle (°) between the forearm and
arm was measured using a standard goniometer (Smith
and Nephew Rolyan Inc., Menomomee Falls, WI)
[1,16]. For each measurement, the axis of rotation of
the elbow joint was aligned with the axis of the goniometer. The proximal arm of the goniometer was
aligned with the acromion process of the scapula and
the distal arm was aligned with the styloid process of
the ulna. Relaxed arm circumference (cm) was measured
with a Gulick tape (Mabis Healthcare, Waukegan, IL) [16]
at half the distance between the acromion process of the
scapula and the olecranon process of the ulna. The maximum girth was determined with the arm horizontally
abducted and the forearm extended. The hanging joint
angle and relaxed arm circumference were always measured on the exercised arm prior to completing the MVIC,
except during the POST assessments at visits 2 and 7
(Figure 1) when hanging joint angle and relaxed arm circumference were measured after the MVIC.
Subjective pain rating

An arm pain intensity scale adapted from McHugh and
Tetro [17] was used to examine the subjective pain rating in the forearm flexors of the exercised arm as described by Beck et al. [13]. The scale ranged from 0 (no
pain at all) to 10 (extremely intense pain). The participants were presented the scale and asked to identify a
single score for arm pain with the arm relaxed and hanging at the participant’s side. The subjective pain rating
was assessed prior to MVIC, except during the POST assessments at visits 2 and 7 (Figure 1) when the subjective pain rating was assessed after the MVIC.
Resting blood pressure and resting heart rate
Figure 2 An example of participant positioning during a
maximal voluntary isometric muscle action.

The resting blood pressure and resting heart rate were
measured after the participant had been sitting quietly for
a period of at least 5 minutes prior to any other testing.

Jenkins et al. Journal of the International Society of Sports Nutrition 2013, 10:33
http://www.jissn.com/content/10/1/33

Systolic and diastolic resting blood pressure were measured in mmHg with an aneroid sphygmomanometer
(MDF Instruments, Agoura Hills, CA) and a stethoscope
(Marshall Nurse Stethoscope, Riverside, IL) according to
the procedures described by Housh et al. [18]. Resting
heart rate was measured by palpating the radial artery at
the anterior-lateral surface of the wrist in line with the
base of the thumb, just medial to the styloid process of the
radius. Once the pulse was located, the number of beats
that occurred in 30 s was measured and multiplied by two
to calculate the resting heart rate (bpm).

Statistical analyses

Four separate two-way repeated measures analyses of
variance (ANOVAs) (condition [ANA vs. PLA] x time
[PRE vs. POST vs. 24 h vs. 48 h vs. 72 h]) were used to
analyze PT, hanging joint angle, relaxed arm circumference, and subjective pain rating. Three separate twoway repeated measures ANOVAs (condition [ANA vs.
PLA] × time [PRE vs. 72 h]) were used to analyze systolic blood pressure, diastolic blood pressure, and resting heart rate. When appropriate, follow-up analyses
included one-way repeated measures ANOVAs and
Bonferonni-corrected dependent samples t-tests. All
statistical analyses were performed using IBM SPSS v.
21 (Chicago, IL), and a type I error rate of 5% was considered statistically significant for all comparisons.

Results
There were no condition x time (p > 0.05) interactions, there
were no main effects for condition (p > 0.05), but there
were main effects for time for PT (p < 0.001), hanging
arm joint angle (p < 0.001), relaxed arm circumference
(p < 0.001), and subjective pain rating (p < 0.001). The
marginal means for PT (collapsed across condition) decreased (p < 0.001) from PRE to POST, increased (p =
0.001) from POST to 24 h, and then plateaued (p > 0.05)
from 48 h to 72 h (Figure 3a). The marginal means for
hanging joint angle (collapsed across condition) decreased (p < 0.001) from PRE to POST and then did not
change (p > 0.05) from POST to 72 h (Figure 3b). The
marginal means for relaxed arm circumference (collapsed across condition) increased from PRE to POST
(p < 0.001) and then plateaued (p > 0.05) from POST to
72 h (Figure 3c). The marginal means for subjective
pain ratings (collapsed across condition) increased (p <
0.001) from PRE to POST, but did not change (p > 0.05)
from POST to 72 h (Figure 3d).
There were no condition x time (p > 0.05) interactions
and no main effects for condition (p > 0.05) or time (p >
0.05) for systolic blood pressure (Figure 4a), diastolic blood
pressure (Figure 4b), or resting heart rate (Figure 4c).
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Discussion
The results of the present study did not support our original hypotheses that ANA would improve the recovery
of PT, hanging joint angle, relaxed arm circumference,
or subjective pain ratings compared to PLA in response
to eccentric-induced muscle damage. The protocol used
in the present study has been used to elicit muscle damage in previous studies [6,13,19,20]. For example, Beck
et al. [13] demonstrated 21-43% decreases in PT of the
forearm flexors, while Cockburn et al. [20] reported 1520% decreases in leg flexion PT. The 23-44% decreases
in PT observed in the present study were consistent with
Beck et al. [13], but greater than Cockburn et al. [20],
which may have been related to the muscle group studied. Nevertheless, Warren et al. [2] suggested that PT is
the single best non-invasive indicator of muscle damage
resulting from eccentric exercise, therefore, the results
of the present study suggested that the magnitude of
muscle damage that occurred was consistent with or
greater than previous studies using the same protocol.
Interestingly, these previous studies [13,20] and others
[10] have also demonstrated that this muscle damage
protocol has elicited decreases in PT that were sensitive
to dietary supplement interventions to improve recovery.
However, in the present study there were no differences
between ANA and PLA conditions during the recovery of
PT, hanging joint angle, relaxed arm circumference, or
subjective pain rating within 72 h after eccentric exercise.
Thus, our conclusion was that ANA supplementation had
no effect on recovery of muscle strength, joint stiffness,
arm swelling, or pain using this model of muscle damage.
Connelly et al. [10] demonstrated that 8 days of cherry
juice supplementation attenuated losses in isometric
forearm flexion PT following a bout of eccentric exercise
when compared with a placebo. The authors [10] hypothesized that the preservation of strength was likely
due to the anti-inflammatory and antioxidant properties
of the cherry juice. Similarly, Beck et al. [13] showed less
reductions in isometric forearm flexion PT after eccentric exercise when participants supplemented with protease enzymes compared to placebo. Beck et al. [13]
hypothesized that the improved recovery may have been
caused by decreases in acute inflammation as a result of
improved return of interstitial fluid to the bloodstream
and decreased production of prostaglandins with protease supplementation. In contrast, Rawson et al. [21]
failed to show an effect of creatine supplementation on
the recovery of isometric forearm flexion strength following eccentric exercise. The authors [21] hypothesized
that the mechanical loads placed on the muscle were too
great for creatine to display any membrane-stabilizing
effects. Likewise, the results of the current study indicated that there were no differences between the ANA
and PLA conditions for the decreases in and recovery of
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Figure 3 Recovery of the non-invasive measures of muscle function. Data presented are means ± standard error of the mean for (a)
isometric forearm flexion strength (Nm), (b) hanging joint angle (°), (c) relaxed arm circumference (cm), and (d) subjective pain ratings during the
supplement (dashed line, open circles; ANA) and placebo (solid line, closed circles; PLA) conditions assessed before (PRE), immediately after
(POST), and 24 h, 48 h, and 72 h after a bout of maximal eccentric exercise. For the marginal means (collapsed across condition), *PRE > POST,
24 h, 48 h, and 72 h (p < 0.05); †POST < PRE, 24 h, 48 h, and 72 h (p < 0.05); #PRE < POST, 24 h, 48 h, and 72 h (p < 0.05).

PT following the eccentric exercise protocol. It is possible, however, that ANA may reduce inflammation
under other physiological conditions. For example, obesity and aging are associated with increased baseline systemic inflammation that is driven by greater secretion of
pro-inflammatory cytokines compared to young, healthy
individuals [22-24]. Future studies should examine the
effects of ANA on the inflammation associated with
obesity and aging.
Studies on the effects of ANA in animal models
[11,12] have demonstrated that ANA exerts antiinflammatory effects via inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) and
NFkB phosphorylation. It has also been shown [12]
that ANA may reduce pro-inflammatory cytokine (i.e.
TNF-α, IL-6, and IL-1β) production. Despite evidence
that ANA has anti-inflammatory effects [12], as well as
evidence that dietary supplementation may improve
the recovery of strength after eccentric-induced muscle
damage [10,13], ANA supplementation had no discernable effect on PT or the other measures of muscle
function following eccentric-induced muscle damage.
It is possible that the pathways by which ANA may
elicit anti-inflammatory effects may not influence
the recovery of muscle function following eccentricinduced muscle damage. Future studies should investigate the effects of ANA on pro-inflammatory cytokine
responses after eccentric exercise.

Eccentric-induced muscle damage may cause muscle
shortening without neural activation as a result of calcium leakage from the sarcoplasmic reticulum [1]. It has
also been suggested [25] that the movement of cells and
fluid from the circulation into the interstitial spaces
surrounding muscle fibers results in inflammation and
edema after eccentric exercise. Therefore, previous studies have utilized the hanging joint angle [10,13] and
relaxed arm circumference [1,13,16], respectively, as
markers of eccentric-induced muscle damage. However,
when these indices have been used to assess the ability
of dietary supplements to enhance recovery after heavy
eccentric exercise, they have been unable to detect a
treatment effect [10,13]. Muscle soreness, assessed by
the subjective pain rating in the present study, is one of
the most commonly used measures of exercise-induced
muscle injury [2]. However, Warren et al. [2] suggested
that soreness correlates poorly with muscle function. In
the current study, the patterns of recovery for hanging
joint angle, relaxed arm circumference, and subjective
pain ratings were similar in the ANA and PLA conditions (Figure 3b). Therefore, the lack of effect of supplementation on the hanging joint angle and relaxed
arm circumference in these studies [10,13], the poor
correlation between muscle function and soreness [2],
and the results of the present study have collectively
suggested that these indicators of muscle damage may
not be sensitive to dietary supplement interventions to
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Figure 4 Heart rate and blood pressure. Data presented are means ± standard error of the mean for (a) systolic blood pressure (mmHg), (b)
diastolic blood pressure (mmHg), and (c) heart rate (bpm) during the supplement (dashed line, open circles; ANA) and placebo (solid line, closed
circles; PLA) conditions assessed at baseline (visits 1 or 6)and 72 h after the bout of maximal eccentric exercise.

improve recovery from eccentric-induced muscle damage. Future studies may wish to consider these findings
when selecting outcome variables for assessing the efficacy of dietary supplementation for reducing muscle
damage.
A secondary objective of this study was to examine the
effects of 10 days of ANA dietary supplementation on
resting heart rate and blood pressure. As a minor alkaloid with a similar chemical structure to nicotine, we hypothesized that ANA would cause moderate decreases
in systolic and diastolic blood pressure and small increases in resting heart rate. Previous studies [14,26,27]
have shown that acute nicotine exposure causes an
increase heart rate and blood pressure through stimulation of the sympathetic nervous system. Minami et al.
[28] showed that smoking cessation caused a reduction
in heart rate, which implied that chronic nicotine use

may elevate heart rate. However, cross sectional studies
[26,29] have shown that systolic and diastolic blood
pressures are lower in smokers than in non-smokers. The
results of the present study indicated that, over a period of
10 days, ANA had no effect on heart rate or blood pressure compared to placebo. Thus, ANA supplementation
may be safe regarding short-term use (10 days) on resting
heart rate and blood pressure. However, future studies
may wish to examine the acute and chronic effects of
ANA consumption on blood pressure and heart rate to
further discern its safety.

Conclusions
In conclusion, ANA supplementation had no effect on the
recovery of muscle strength, hanging joint angle, arm
swelling, or subjective pain ratings after a bout of maximal
eccentric exercise in the forearm flexors. Therefore, ANA
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may not be beneficial for those seeking to improve recovery from heavy exercise training or competition. Future
studies, however, should examine the effects of ANA on
the pro-inflammatory cytokine responses to eccentricinduced muscle damage. It is also possible that, due to the
pathways by which ANA exerts its anti-inflammatory
properties, ANA supplementation may have an effect on
chronic, low-grade inflammation such as the inflammation
observed in obese and elderly individuals.
Abbreviations
ANA: Anatabine; ANOVA: Analysis of variance; DOMS: Delayed onset muscle
soreness; IL-1β: Interleukin-1 beta; IL-6: Interleukin 6; MVICs: Maximal
voluntary isometric muscle actions; PLA: Placebo; PT: Peak torque;
STAT3: Signal Transducer and Activator of Transcription 3; TNF-α: Tumor
necrosis factor alpha.
Competing interests
TJH and JTC are the principle or co-investigators of currently-funded
research or service contracts at the University of Nebraska-Lincoln with Rock
Creek Pharmaceuticals, Abbott Nutrition, General Nutrition Center, and
Stepan Lipid Nutrition. NDMJ, DAT, KCC, HCB, and RWL Jr. declare that they
have no competing interests.
Authors’ contributions
NDMJ was the primary manuscript writer, and carried out data acquisition,
data analysis and data interpretation. DAT, KCC, HCB, and RWL Jr. were
significant contributors to data acquisition and were important manuscript
reviewers/revisers. GOJ, RJS, and TJH were significant manuscript reviewers/
revisers and were substantial contributors to conception and design of this
study. JTC was the primary manuscript reviewer/reviser, a substantial
contributor to concept and design, and contributed to data analysis and
interpretation. All authors read and approved the final manuscript.
Authors’ information
NDMJ, KCC, and HCB are currently Ph.D. students and research assistants in
the Human Performance Laboratory in the Department of Nutrition and
Health Sciences at the University of Nebraska-Lincoln. DAT and RWL Jr. were
research assistants in the Human Performance Laboratory at the time of data
acquisition and manuscript preparation. GOJ is a professor-emeritus in the
Department of Nutrition and Health Sciences at UNL. JTC, TJH, and RJS are
faculty in the Department of Nutrition and Health Sciences at UNL and
mentor graduate students in the Human Performance Laboratory.
Acknowledgements
This study was funded by a research grant from Rock Creek Pharmaceuticals,
Inc. Rock Creek Pharmaceuticals, Inc. had no involvement in the data
collection, analysis and interpretation of the data, writing of the manuscript,
or in the decision to submit the manuscript for publication.
Received: 18 June 2013 Accepted: 18 July 2013
Published: 22 July 2013
References
1. Clarkson PM, Nosaka K, Braun B: Muscle function after exercise-induced
muscle damage and rapid adaptation. Med Sci Sports Exerc 1992, 24:512–520.
2. Warren GL, Lowe DA, Armstrong RB: Measurement tools used in the study
of eccentric contraction-induced injury. Sports Med 1999, 27:43–59.
3. Newham DJ, McPhail G, Mills KR, Edwards RH: Ultrastructural changes after
concentric and eccentric contractions of human muscle. J Neurol Sci
1983, 61:109–122.
4. Friden J, Sjostrom M, Ekblom B: A morphological study of delayed muscle
soreness. Experientia 1981, 37:506–507.
5. Proske U, Morgan DL: Muscle damage from eccentric exercise:
mechanism, mechanical signs, adaptation and clinical applications.
J Physiol 2001, 537:333–345.
6. Beck TW, Kasishke PR 2nd, Stock MS, DeFreitas JM: Neural contributions to
concentric vs. eccentric exercise-induced strength loss. J Strength Cond
Res 2012, 26:633–640.

7.

8.

9.

10.

11.

12.

13.

14.
15.
16.
17.

18.
19.
20.

21.

22.

23.
24.

25.
26.
27.
28.

29.

Page 8 of 8

Prasartwuth O, Taylor JL, Gandevia SC: Maximal force, voluntary activation
and muscle soreness after eccentric damage to human elbow flexor
muscles. J Physiol 2005, 567:337–348.
Lund H, Vestergaard-Poulsen P, Kanstrup IL, Sejrsen P: The effect of passive
stretching on delayed onset muscle soreness, and other detrimental
effects following eccentric exercise. Scand J Med Sci Sports 1998,
8:216–221.
Tokmakidis SP, Kokkinidis EA, Smilios I, Douda H: The effects of ibuprofen
on delayed muscle soreness and muscular performance after eccentric
exercise. J Strength Cond Res 2003, 17:53–59.
Connolly DA, McHugh MP, Padilla-Zakour OI, Carlson L, Sayers SP: Efficacy
of a tart cherry juice blend in preventing the symptoms of muscle
damage. Br J Sports Med 2006, 40:679–683. discussion 683.
Paris D, Beaulieu-Abdelahad D, Bachmeier C, Reed J, Ait-Ghezala G, Bishop
A, Chao J, Mathura V, Crawford F, Mullan M: Anatabine lowers Alzheimer’s
Abeta production in vitro and in vivo. Eur J Pharmacol 2011, 670:384–391.
Paris D, Beaulieu-Abdelahad D, Abdullah L, Bachmeier C, Ait-Ghezala G,
Reed J, Verma M, Crawford F, Mullan M: Anti-inflammatory activity of
anatabine via inhibition of STAT3 phosphorylation. Eur J Pharmacol 2013,
698:145–153.
Beck TW, Housh TJ, Johnson GO, Schmidt RJ, Housh DJ, Coburn JW, Malek
MH, Mielke M: Effects of a protease supplement on eccentric
exercise-induced markers of delayed-onset muscle soreness and muscle
damage. J Strength Cond Res 2007, 21:661–667.
Haass M, Kubler W: Nicotine and sympathetic neurotransmission.
Cardiovasc Drugs Ther 1997, 10:657–665.
Connolly DA, Reed BV, McHugh MP: The repeated bout effect: Does
evidence for a crossover effect exist? J Sports Sci Med 2002, 1:80–86.
Nosaka K, Clarkson PM: Muscle damage following repeated bouts of high
force eccentric exercise. Med Sci Sports Exerc 1995, 27:1263–1269.
McHugh MP, Tetro DT: Changes in the relationship between joint angle
and torque production associated with the repeated bout effect. J Sports
Sci 2003, 21:927–932.
Housh TJ, Cramer JT, Weir JP, Beck TW, Johnson GO: Physical Fitness
Laboratories on a Budget. Scottsdale, AZ: Holcomb Hathaway Publishers; 2009.
Beck TW, Kasishke PR 2nd, Stock MS, Defreitas JM: Eccentric exercise does not
affect common drive in the biceps brachii. Muscle Nerve 2012, 46:759–766.
Cockburn E, Robson-Ansley P, Hayes PR, Stevenson E: Effect of volume of
milk consumed on the attenuation of exercise-induced muscle damage.
Eur J Appl Physiol 2012, 112:3187–3194.
Rawson ES, Gunn B, Clarkson PM: The effects of creatine supplementation
on exercise-induced muscle damage. J Strength Cond Res 2001,
15:178–184.
vanGreevenbroek MM, Schalkwijk CG, Stehouwer CD: Obesity-associated
low-grade inflammation in type 2 diabetes mellitus: causes and
consequences. Neth J Med 2013, 71:174–187.
Masternak MM, Bartke A: Growth hormone, inflammation and aging.
Pathobiol Aging Age Relat Dis 2012, 2:17293. doi:10.3402/pba.v2i0.17293.
Osorio FG, Barcena C, Soria-Valles C, Ramsay AJ, de Carlos F, Cobo J, Fueyo
A, Freije JM, Lopez-Otin C: Nuclear lamina defects cause ATM-dependent
NF-kappaB activation and link accelerated aging to a systemic
inflammatory response. Genes Dev 2012, 26:2311–2324.
Connolly DA, Sayers SP, McHugh MP: Treatment and prevention of
delayed onset muscle soreness. J Strength Cond Res 2003, 17:197–208.
Omvik P: How smoking affects blood pressure. Blood Press 1996, 5:71–77.
Lee IW, Ahn SK, Choi EH, Lee SH: Urticarial reaction following the
inhalation of nicotine in tobacco smoke. Br J Dermatol 1998, 138:486–488.
Minami J, Ishimitsu T, Matsuoka H: Effects of smoking cessation on blood
pressure and heart rate variability in habitual smokers. Hypertension 1999,
33:586–590.
Payne JR, James LE, Eleftheriou KI, Hawe E, Mann J, Stronge A, Banham K,
World M, Humphries SE, Pennell DJ, Montgomery HE: The association of
left ventricular mass with blood pressure, cigarette smoking and alcohol
consumption; data from the LARGE Heart study. Int J Cardiol 2007,
120:52–58.

doi:10.1186/1550-2783-10-33
Cite this article as: Jenkins et al.: The effects of anatabine on noninvasive indicators of muscle damage: a randomized, double-blind,
placebo-controlled, crossover study. Journal of the International Society of
Sports Nutrition 2013 10:33.

